PALO ALTO, Calif., Aug. 1, 2024 /PRNewswire/ -- Verantos, the global leader in high-validity real-world evidence at scale, today announced that Adam S. Cheifetz, M.D. of Beth Israel Deaconess Medical Center, and Gil Y. Melmed, M.D. of Cedars-Sinai Medicine, have joined its advisory panel for inflammatory bowel disease (IBD). As senior faculty and experts, they will provide expert input on observational research powered by Verantos' Inflammatory Bowel Disease Pragmatic Registry.
IRVINE, Calif., Aug. 30, 2021 (GLOBE NEWSWIRE) -- Biomerica Inc. (NASDAQ: BMRA) today announced it expects final patient enrollment in its endpoint clinical trial for its InFoods® diagnostic-guided therapy (DGT), designed to alleviate Irritable Bowel Syndrome (IBS) symptoms. The clinical trial is being conducted by Mayo Clinic, Beth Israel Deaconess Medical Center Inc., a Harvard Medical School Teaching Hospital, Houston Methodist hospital and the University of Michigan as primary enrollment centers for this study.